phase 2_completion
saveUsynova Pharmaceuticals Ltd — UA-021 (Phase II Trial Completion)
community read0 votes
Therapy area: Immunology. Indication: Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis
Therapy area: Immunology. Indication: Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis